Cargando…

A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas

Recent literature suggests that most widely used ovarian cancer (OVCA) cell models do not recapitulate the molecular features of clinical tumors. To address this limitation, we generated 18 cell lines and 3 corresponding patient-derived xenografts predominantly from high-grade serous carcinoma (HGSO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thu, Kelsie L., Papari-Zareei, Mahboubeh, Stastny, Victor, Song, Kai, Peyton, Michael, Martinez, Victor D., Zhang, Yu-An, Castro, Isabel B., Varella-Garcia, Marileila, Liang, Hanquan, Xing, Chao, Kittler, Ralf, Milchgrub, Sara, Castrillon, Diego H., Davidson, Heather L., Reynolds, C Patrick, Lam, Wan L., Lea, Jayanthi, Gazdar, Adi F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584155/ https://www.ncbi.nlm.nih.gov/pubmed/28881577 http://dx.doi.org/10.18632/oncotarget.9929

Ejemplares similares

Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines
por: Gandhi, Jeet, et al.
Publicado: (2009)

Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay
por: Varella-Garcia, Marileila
Publicado: (2006)

Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer
por: Martinez, Victor D., et al.
Publicado: (2014)

Tumor core biopsies adequately represent immune microenvironment of high-grade serous carcinoma
por: Lara, Olivia D., et al.
Publicado: (2019)

Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer
por: Coe, Bradley P., et al.
Publicado: (2013)

Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
por: Ariyawutyakorn, Witthawat, et al.
Publicado: (2016)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer
por: Cai, Ling, et al.
Publicado: (2021)

Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques
por: Bellini, Marilanda Ferreira, et al.
Publicado: (2010)

Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease
por: Haley, James, et al.
Publicado: (2016)

Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma
por: Ostmeyer, Jared, et al.
Publicado: (2020)

High grade serous ovarian carcinomas originate in the fallopian tube
por: Labidi-Galy, S. Intidhar, et al.
Publicado: (2017)

Chromosomal imbalances are uncommon in chagasic megaesophagus
por: Bellini, Marilanda F, et al.
Publicado: (2010)

Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells
por: Soh, Junichi, et al.
Publicado: (2009)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Surprise Lymph Node Histology in a Patient with Ovarian Serous Carcinoma
por: Karunanithi, Jayanthi, et al.
Publicado: (2020)

Focal Laser Photocoagulation for Central Serous Chorioretinopathy in Under-Represented Populations: A Retrospective Case Series
por: Sangal, Kajal, et al.
Publicado: (2022)

Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2023)

Lung Adenocarcinoma of Never Smokers and Smokers Harbor Differential Regions of Genetic Alteration and Exhibit Different Levels of Genomic Instability
por: Thu, Kelsie L., et al.
Publicado: (2012)

Oncogenes in high grade serous adenocarcinoma of the ovary
por: Manasa, Pacharla, et al.
Publicado: (2020)

Study on Magnetization Roasting Kinetics of High-Iron and Low-Silicon Red Mud
por: Xie, Lei, et al.
Publicado: (2023)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
por: Adamson, A. W., et al.
Publicado: (2023)

Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures
por: Brcic, Luka, et al.
Publicado: (2019)

Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer
por: Adamson, A.W., et al.
Publicado: (2023)

Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner
por: Frink, Robin E., et al.
Publicado: (2016)

Lipid Alterations in Early-Stage High-Grade Serous Ovarian Cancer
por: Iurova, M. V., et al.
Publicado: (2022)

Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020)

Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer
por: Nath, Aritro, et al.
Publicado: (2021)

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
por: Lee, Sanghoon, et al.
Publicado: (2020)

Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
por: Gross, Amy L., et al.
Publicado: (2010)

Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer
por: Natanzon, Yanina, et al.
Publicado: (2018)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Educational Case: High-Grade Serous Carcinoma of the Ovary
por: Bunde, Sophia, et al.
Publicado: (2021)

Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020)

High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
por: Hatano, Yuichiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5hgdutc35lcpnf7kb1vr4ngl0i